AlzeCure Pharma - ACD440 - A novel non-opioid analgesic
AlzeCure Pharma - Capital Market Day May 17th
Alzecure Pharma - Naventus Life Science Summit 2021
AlzeCure Pharma - Sitdown
BioStock Investor Pitch | AlzeCure Pharma | December 2022
AlzeCure - About Alzstatin
BioStock | AlzeCure | CEO interview about the company's development and the rights issue | 2022
Alzecure Pharma - Market Update
AlzeCure Pharma: Framsteg och framtidstro inom Alzheimers och smärtlindring
AlzeCure science & market update with prof. Henrik Zetterberg on Alzheimer’s, biomarkers & Alzstatin
AlzeCure Alzheimer's Disease & NeroResore
AlzeCure Pharma at Carlsquare Nordic Life Science Investor Day 17 Nov. 2022
AlzeCure Pharma – executive interview
BioStock Investor Meeting March 2022 | AlzeCure
AlzeCure - About Alzheimer's disease.
Så vill AlzeCure Pharma ta hand om demensen i en åldrande befolkning
Alzecure Redeye Growth day, June 7, 2021
AlzeCure Pharmas Innovativa Läkemedelsplattformar: En Intervju med Johan Sandin, CSO
ACD440 – A novel non-opioid analgesic - From AlzeCure´s live event. October 23, 2024
Top foods to prevent Alzheimer's. Follow link to full video. #memoryhealth #alzecure #alzheimersday
